Novartis and RetinAI will collaborate on artificial intelligence projects in ophthalmology and digital health, according to a press release.
The first project will support a multicenter international clinical study involving more than 500 patients with wet age-related macular degeneration. The study will investigate the influence of OCT image solutions using AI to assess disease activity, according to the release. RetinAI’s Discovery data management platform will be used to process data at scale across imaging platforms and devices.
“Our Discovery platform and AI tools are enablers
Uncategorized